B.C. Widemann
Pediatric Branch
National Cancer Institute
National Institutes of Health
Bethesda
USA
Name/email consistency: high
- The plasma pharmacokinetics and cerebrospinal fluid penetration of the thymidylate synthase inhibitor raltitrexed (Tomudex) in a nonhuman primate model. Widemann, B.C., Balis, F.M., Godwin, K.S., McCully, C., Adamson, P.C. Cancer Chemother. Pharmacol. (1999)
- Dihydrofolate reductase enzyme inhibition assay for plasma methotrexate determination using a 96-well microplate reader. Widemann, B.C., Balis, F.M., Adamson, P.C. Clin. Chem. (1999)
- Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction. Widemann, B.C., Balis, F.M., Murphy, R.F., Sorensen, J.M., Montello, M.J., O'Brien, M., Adamson, P.C. J. Clin. Oncol. (1997)









